Search research articles
Contact Us
Filters
Showing results (141-150 of 270) with videos related to
Page
of 27
Sort By:
Transplantation
|
June 28, 2022
Expert Opinion Special Feature: Patient Selection for Initial Clinical Trials of Pig Organ Transplantation
Richard N Pierson, James S Allan, David K C Cooper, et al.
JAMA Cardiology
|
March 12, 2025
Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF: The HuMAIN-HFpEF Randomized Clinical Trial
Ambarish Pandey, Gregory D Lewis, Barry A Borlaug, et al.
Circulation. Heart Failure
|
May 7, 2017
INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction): Rationale and Design
Yogesh N V Reddy, Gregory D Lewis, Sanjiv J Shah, et al.
JACC. Heart Failure
|
March 12, 2018
Post-Exercise Oxygen Uptake Recovery Delay: A Novel Index of Impaired Cardiac Reserve Capacity in Heart Failure
Cole S Bailey, Luke T Wooster, Mary Buswell, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
November 22, 2024
Extended duration of ex-vivo perfusion is associated with worse survival in donation after circulatory death heart recipients: A national database analysis
Ruby Singh, George Olverson, Kristian Punu, et al.
Circulation. Heart Failure
|
January 1, 2015
Exercise oscillatory ventilation in patients with Fontan physiology
Ashwin S Nathan, Brittani Loukas, Lilamarie Moko, et al.
American Heart Journal
|
February 28, 2020
Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserved ejection fraction (CAPACITY HFpEF)
James E Udelson, Gregory D Lewis, Sanjiv J Shah, et al.
Cardiovascular Research
|
November 30, 2022
Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directions
Anthony E Peters, Jasper Tromp, Sanjiv J Shah, et al.
The European Respiratory Journal
|
January 8, 2022
The association of lung function and pulmonary vasculature volume with cardiorespiratory fitness in the community
Jenna McNeill, Ariel Chernofsky, Matthew Nayor, et al.
Circulation. Cardiovascular Imaging
|
December 16, 2015
Exercise-Induced Left Ventricular Remodeling Among Competitive Athletes: A Phasic Phenomenon
Rory B Weiner, James R DeLuca, Francis Wang, et al.
Page
of 27
Search research articles
Search
Showing results (141-150 of 270) with videos related to
Sort By:
Page
of 27
Transplantation
|
June 28, 2022
Expert Opinion Special Feature: Patient Selection for Initial Clinical Trials of Pig Organ Transplantation
Richard N Pierson, James S Allan, David K C Cooper, et al.
JAMA Cardiology
|
March 12, 2025
Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF: The HuMAIN-HFpEF Randomized Clinical Trial
Ambarish Pandey, Gregory D Lewis, Barry A Borlaug, et al.
Circulation. Heart Failure
|
May 7, 2017
INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction): Rationale and Design
Yogesh N V Reddy, Gregory D Lewis, Sanjiv J Shah, et al.
JACC. Heart Failure
|
March 12, 2018
Post-Exercise Oxygen Uptake Recovery Delay: A Novel Index of Impaired Cardiac Reserve Capacity in Heart Failure
Cole S Bailey, Luke T Wooster, Mary Buswell, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
November 22, 2024
Extended duration of ex-vivo perfusion is associated with worse survival in donation after circulatory death heart recipients: A national database analysis
Ruby Singh, George Olverson, Kristian Punu, et al.
Circulation. Heart Failure
|
January 1, 2015
Exercise oscillatory ventilation in patients with Fontan physiology
Ashwin S Nathan, Brittani Loukas, Lilamarie Moko, et al.
American Heart Journal
|
February 28, 2020
Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserved ejection fraction (CAPACITY HFpEF)
James E Udelson, Gregory D Lewis, Sanjiv J Shah, et al.
Cardiovascular Research
|
November 30, 2022
Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directions
Anthony E Peters, Jasper Tromp, Sanjiv J Shah, et al.
The European Respiratory Journal
|
January 8, 2022
The association of lung function and pulmonary vasculature volume with cardiorespiratory fitness in the community
Jenna McNeill, Ariel Chernofsky, Matthew Nayor, et al.
Circulation. Cardiovascular Imaging
|
December 16, 2015
Exercise-Induced Left Ventricular Remodeling Among Competitive Athletes: A Phasic Phenomenon
Rory B Weiner, James R DeLuca, Francis Wang, et al.
Page
of 27